XML 47 R36.htm IDEA: XBRL DOCUMENT
v3.24.3

EQUITY AND NONCONTROLLING INTERESTS (Tables) | 9 Months Ended
--- | ---
Sep. 28, 2024
Equity [Abstract] |
Schedule of Reconciliation of the Numerator and Denominator in the Computations of the Basic and Diluted Earnings Per Share | The following table reconciles the numerator and denominator in the computations of basic and diluted earnings per share:
| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
| (in thousands)
Numerator: |  |  |  |  |  |  |
Net income | $ | 70,295 |  |  | $ | 88,021 |  |  | $ | 239,038 |  |  | $ | 291,418 |
Less: Net income attributable to noncontrolling interests | 638 |  |  | 632 |  |  | 2,340 |  |  | 3,878 |
Net income attributable to Charles River Laboratories International Inc. | 69,657 |  |  | 87,389 |  |  | 236,698 |  |  | 287,540 |
Calculation of net income per share attributable to Charles River Laboratories International Inc. common shareholders |  |  |  |  |  |  |
Net income attributable to Charles River Laboratories International Inc. | $ | 69,657 |  |  | $ | 87,389 |  |  | $ | 236,698 |  |  | $ | 287,540 |
Less: Adjustment of redeemable noncontrolling interest (1) | 379 |  |  | — |  |  | 1,081 |  |  | — |
Less: Incremental dividends attributable to noncontrolling interest holders (2) | 599 |  |  | — |  |  | 9,621 |  |  | — |
Net income available to Charles River Laboratories International Inc. common shareholders | $ | 68,679 |  |  | $ | 87,389 |  |  | $ | 225,996 |  |  | $ | 287,540 |
Denominator: |  |  |  |  |  |  |
Weighted-average shares outstanding - Basic | 51,394 |  |  | 51,283 |  |  | 51,461 |  |  | 51,199 |
Effect of dilutive securities: |  |  |  |  |  |  |
Stock options, restricted stock units and performance share units | 189 |  |  | 324 |  |  | 252 |  |  | 294 |
Weighted-average shares outstanding - Diluted | 51,583 |  |  | 51,607 |  |  | 51,713 |  |  | 51,493 |
Anti-dilutive common stock equivalents (3) | 746 |  |  | 588 |  |  | 505 |  |  | 514 |
(1) Represents adjustments of redeemable noncontrolling interest that impact retained earnings.
(2) Represents incremental declared and undeclared dividends attributable to Noveprim noncontrolling interest holders who are entitled to preferential dividends for fiscal year 2024.
(3) These common stock equivalents were outstanding for the periods presented, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.
Schedule of Accumulated Other Comprehensive Income (Loss) | Changes to each component of accumulated other comprehensive income (loss), net of income taxes, are as follows:
| Foreign Currency Translation Adjustment and Other |  | Pension and Other Post-Retirement Benefit Plans |  | Net Unrealized (Loss) Gain on Cash Flow Hedge |  | Total
| (in thousands)
December 30, 2023 | $ | (149,999) |  |  | $ | (47,167) |  |  | $ | 739 |  |  | $ | (196,427) |
Other comprehensive income (loss) before reclassifications | 4,054 |  |  | 1,038 |  |  | (688) |  |  | 4,404 |
Net current period other comprehensive income (loss) | 4,054 |  |  | 1,038 |  |  | (688) |  |  | 4,404 |
Income tax expense (benefit) | 757 |  |  | 256 |  |  | (165) |  |  | 848 |
September 28, 2024 | $ | (146,702) |  |  | $ | (46,385) |  |  | $ | 216 |  |  | $ | (192,871) |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration